Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tamami Shino is active.

Publication


Featured researches published by Tamami Shino.


Nephrology | 2002

Predialysis factors related to prognosis in type 2 diabetic patients on chronic dialysis in Japan

Tomonari Okada; Toshiyuki Nakao; Hiroshi Matsumoto; Hirgmi Hidaka; Maki Yoshino; Tamami Shino; Yume Nagaoka; Humihiro Takeguchi; Hideaki Iwasawa; Ryo Tomaru

SUMMARY: We investigated to clarify the predialysis factors associated with prognosis in type 2 diabetic patients entering chronic dialysis. One hundred and twenty‐four type 2 diabetic patients who started chronic dialysis in our department between January 1992 and November 2000 were studied. the variables in the predialysis period and those at initiation of dialysis were collected and evaluated in association with prognosis after a mean follow up of 37 ± 23 months from initiation of dialysis by using Coxs proportional‐hazards model. the 1‐, 3‐, and 5‐year survival rates after initiating chronic dialysis were 92.7, 74.6, and 56.5%, respectively. During follow up, 40 patients died. Univariate analysis demonstrated that serum albumin (Alb) levels, haemoglobin A1c, and no preparation for permanent vascular or peritoneal access at initiation of dialysis were significantly associated with prognosis. In multivariate analysis, Alb levels (hazard ratio, 2.09, per decrease of 1 g/dL; confidence interval, 1.05–4.19), and age (1.54, per decrease of 10 years; 1.06–2.22) at initiation of dialysis remained significant predictors of mortality. In conclusion, Alb levels and age at initiation of dialysis are associated with prognosis in type 2 diabetic patients on chronic dialysis. It should be elucidated whether improvement of Alb levels at initiation of dialysis would have a favourable influence on survival after diabetic patients with renal failure are entered into chronic dialysis.


Internal Medicine | 1998

Influence of Erythropoietin Treatment on Hemoglobin A1c Levels in Patients with Chronic Renal Failure on Hemodialysis

Toshiyuki Nakao; Hiroshi Matsumoto; Tomonari Okada; Myongi Han; Hiromi Hidaka; Maki Yoshino; Tamami Shino; Chikayuki Yamada; Yume Nagaoka


Internal Medicine | 2007

Association between Markers of Glycemic Control, Cardiovascular Complications and Survival in Type 2 Diabetic Patients with End-Stage Renal Disease

Tomonari Okada; Toshiyuki Nakao; Hiroshi Matsumoto; Tamami Shino; Yume Nagaoka; Ryo Tomaru; Toshikazu Wada


Kidney International | 1999

Low-density lipoprotein apheresis retards the progression of hyperlipidemic overt diabetic nephropathy.

Toshiyuki Nakao; Maki Yoshino; Hiroshi Matsumoto; Tomonari Okada; Myongi Han; Hiromi Hidaka; Tamami Shino; Chikayuki Yamada; Yume Nagaoka; Tadashi Miyahara


Japanese Journal of Nephrology | 2001

Serial changes in body composition in patients with chronic renal failure on peritoneal dialysis

Yoshie Kanazawa; Toshiyuki Nakao; Hiroshi Matsumoto; Tomonari Okada; Hiromi Hidaka; Maki Yoshino; Tamami Shino; Yume Nagaoka; Fumihiro Takeguchi; Hideaki Iwasawa; Ryo Tomaru


Japanese Journal of Nephrology | 1999

Relationship of renal lesions with urinary protein excretion in patients with overt diabetic nephropathy

Tomonari Okada; Hiroshi Matsumoto; Toshiyuki Nakao; Yume Nagaoka; Chikayuki Yamada; Tamami Shino; Maki Yoshino; Hiromi Hidaka; Myongi Han; Ootani M; Shimizu T


Nihon Toseki Igakkai Zasshi | 2005

Relationship between glycohemoglobin and glycated albumin in chronic dialysis patients

Tomonari Okada; Hiroshi Matsumoto; MyeongGi Han; Tamami Shino; Yume Nagaoka; Humihiro Takeguchi; Ryo Tomaru; Hideaki Iwasawa; Toshikazu Wada; Asako Gondo; Toshiyuki Nakao


Japanese Journal of Nephrology | 1999

Evaluation of fat nutrition in the energy intake on low protein diets for patients with chronic renal failure

Yoshie Kanazawa; Toshiyuki Nakao; Hiroshi Matsumoto; Tomonari Okada; Hiromi Hidaka; Myongi Han; Maki Yoshino; Tamami Shino; Chikayuki Yamada; Yume Nagaoka


Nihon Toseki Igakkai Zasshi | 2007

The effect of erythropoietin treatment on glycohemoglobin values in diabetic hemodialysis patients-an examination based on the relationship between glycohemoglobin and glycated albumin-

Tomonari Okada; Tamami Shino; Ryo Tomaru; Toshiyuki Nakao; Katsusuke Ikeda


Nihon Toseki Igakkai Zasshi | 2003

Longitudinal changes in dialysate CA125 levels in peritoneal dialysis patients

Tomonari Okada; Toshiyuki Nakao; Hiroshi Matsumoto; Hiromi Hidaka; Maki Yoshino; Tamami Shino; Yume Nagaoka; Fumihiro Takeguchi; Hideaki Iwasawa; Ryo Tomaru; Toshikazu Wada

Collaboration


Dive into the Tamami Shino's collaboration.

Top Co-Authors

Avatar

Tomonari Okada

Tokyo Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hiroshi Matsumoto

Jikei University School of Medicine

View shared research outputs
Top Co-Authors

Avatar

Yume Nagaoka

Tokyo Medical University

View shared research outputs
Top Co-Authors

Avatar

Maki Yoshino

Tokyo Medical University

View shared research outputs
Top Co-Authors

Avatar

Hiromi Hidaka

Tokyo Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Myongi Han

Tokyo Medical University

View shared research outputs
Top Co-Authors

Avatar

Ryo Tomaru

Tokyo Medical University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge